Literature DB >> 16237318

Heteromerization and colocalization of TrpV1 and TrpV2 in mammalian cell lines and rat dorsal root ganglia.

A Richard Rutter1, Qing-Ping Ma, Mathew Leveridge, Timothy P Bonnert.   

Abstract

Coassociation of the vanilloid transient receptor potential (Trp) ion channels, TrpV1 and TrpV2, was investigated by immunoprecipitation and immunofluorescence in transfected mammalian cell lines, rat dorsal root ganglia and spinal cord. TrpV1/TrpV2 heteromeric complexes were coimmunoprecipitated from human embryonic kidney cells and F-11 dorsal root ganglion hybridoma cells following their transient coexpression. Immunofluorescent labelling of transfected F-11 cells revealed colocalization of TrpV1 and TrpV2 at the cell surface. Immunoprecipitation from rat dorsal root ganglion lysates identified a minor population of receptor complexes composed of TrpV1/TrpV2 heteromers, consistent with a small proportion of cells double-labelled with TrpV1 and TrpV2 antibodies in rat dorsal root ganglion sections. TrpV1/TrpV2 receptor complexes may represent a functionally distinct ion channel complex that may increase the diversity observed within the Trp ion channel family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237318     DOI: 10.1097/01.wnr.0000185958.03841.0f

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

Review 1.  Heteromerization of TRP channel subunits: extending functional diversity.

Authors:  Wei Cheng; Changsen Sun; Jie Zheng
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

2.  TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception.

Authors:  Una Park; Nisha Vastani; Yun Guan; Srinivasa N Raja; Martin Koltzenburg; Michael J Caterina
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

Review 3.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

4.  Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats.

Authors:  Jun Shen; Lyle E Fox; Jianguo Cheng
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

Review 5.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

6.  Region-specific changes in transient receptor potential vanilloid channel expression in the vasopressin magnocellular system in hepatic cirrhosis-induced hyponatraemia.

Authors:  T P Nedungadi; F R Carreño; J D Walch; C S Bathina; J T Cunningham
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

7.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

Review 8.  What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?

Authors:  Alex Perálvarez-Marín; Pau Doñate-Macian; Rachelle Gaudet
Journal:  FEBS J       Date:  2013-05-28       Impact factor: 5.542

9.  Gastrin-releasing peptide acts via postsynaptic BB2 receptors to modulate inward rectifier K+ and TRPV1-like conductances in rat paraventricular thalamic neurons.

Authors:  M L H J Hermes; M Kolaj; E M Coderre; L P Renaud
Journal:  J Physiol       Date:  2013-01-28       Impact factor: 5.182

Review 10.  TRP channels and analgesia.

Authors:  Louis S Premkumar; Mruvil Abooj
Journal:  Life Sci       Date:  2012-08-14       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.